IP Library Granted Patent US 9,163,268
Granted Patent B2
US 9,163,268 · App. 13/379,654 · Granted Oct 20, 2015

Method for fermentatively preparing L-amino acids

Inventors: Volker F. Wendisch (Bielefeld, DE); Steffen Lindner (Moers, DE); Brigitte Bathe (Salzkotten, DE); Wilfried Claes (Bielefeld, DE)
Assignee: Evonik Degussa GmbH
C12P13/08C12N9/1205C12Y207/01023
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,163,268
App. No.
13/379,654
Granted
Oct 20, 2015
Kind
B2
Abstract

The invention relates to a method for preparing organic-chemical compounds, characterized in that the following steps are carried out: a) fermentation of a microorganism secreting an L-amino acid, which microorganism contains an overexpressed polynucleotide coding for a polypeptide having polyphosphate-dependent NAD + kinase activity, in a fermentation medium, to form a fermentation broth, b) accumulation of said compound in said fermentation broth and/or in the cells of said microorganism. The invention relates to a method for preparing organic-chemical compounds by fermentation of a microorganism in which a polypeptide having polyphosphate-dependent NAD + kinase is overexpressed.

Claims (36)

1. A method for fermentatively producing an L-amino acid product, comprising:

a) fermenting a modified microorganism that secretes L-lysine in a fermentation medium to form a fermentation broth, wherein:

i) compared to an unmodified microorganism or starting strain, said modified microorganism overexpresses a polynucleotide coding for a polypeptide, wherein said polypeptide has polyphosphate-dependent NAD + kinase enzymatic activity and comprises the amino acid sequence of SEQ ID NO:2, SEQ ID NO:4 or SEQ ID NO:6;

ii) compared to an unmodified microorganism, or starting strain, said modified microorganism produces an increased amount of L-lysine;

b) allowing said L-lysine to accumulate in said fermentation broth and/or in the cells of said microorganism;

c) recovering said L-amino acid product from the fermentation broth and/or cells of step b).

2. The method of claim 1 , wherein said polypeptide comprises the amino acid sequence of SEQ ID NO:4 or SEQ ID NO:6.

3. The method of claim 1 , wherein said polypeptide comprises the amino acid sequence of SEQ ID NO:2.

4. The method of claim 3 , wherein said L-amino acid product is a solid product containing at least 10% lysine by weight.

5. The method of claim 3 , wherein said microorganism is a bacterium, yeast or fungus.

6. The method of claim 3 , wherein said microorganism is a bacterium of the genus Corynebacterium or Escherichia.

7. The method of claim 6 , wherein said microorganism is a bacterium of the species Corynebacterium glutamicum or Escherichia coli.

8. The method of claim 7 , wherein said polynucleotide is a recombinant polynucleotide.

9. The method of claim 1 , wherein said polynucleotide comprises the nucleotide sequence of SEQ ID NO:1.

10. The method of claim 1 , wherein said polynucleotide comprises the nucleotide sequence of SEQ ID NO:3 or SEQ ID NO:5.

11. The method of claim 1 , wherein, compared to said unmodified microorganism or starting strain, said modified microorganism comprises either:

a) an increased copy number of said polynucleotide, or

b) a stronger promoter controlling transcription of said polynucleotide.

12. The method of claim 11 , wherein said microorganism is a bacterium of the species Corynebacterium glutamicum and said polypeptide consists of the amino acid sequence of SEQ ID NO:2, SEQ ID NO:4 or SEQ ID NO:6.

13. The method of claim 11 , wherein said microorganism is a bacterium of the species Corynebacterium glutamicum and said L-amino acid product is a concentrated aqueous alkaline solution of purified L-lysine or an aqueous acidic biomass-containing concentrate of L-lysine-containing fermentation broth.

14. The method of claim 11 , wherein said microorganism is a bacterium of the species Corynebacterium glutamicum and said L-amino acid product is a solid product containing at least 10% lysine by weight.

15. The method of claim 14 , wherein said solid product comprises either:

a) a pulverulent or crystalline form of purified or pure L-lysine; or

b) L-lysine and biomass.

16. A method for fermentatively producing an L-amino acid product, comprising:

a) fermenting a modified microorganism that secretes L-lysine in a fermentation medium to form a fermentation broth, wherein:

i) compared to an unmodified microorganism or starting strain, said modified microorganism overexpresses a polynucleotide coding for a polypeptide, wherein said polypeptide has polyphosphate-dependent NAD + kinase enzymatic activity and comprises an amino acid sequence that is at least 80% identical to the amino acid sequence of SEQ ID NO:2;

ii) compared to an unmodified microorganism, or starting strain, said modified microorganism produces an increased amount of L-lysine;

b) allowing said L-lysine to accumulate in said fermentation broth and/or in the cells of said microorganism;

c) recovering said L-amino acid product from the fermentation broth and/or cells of step b).

17. The method of claim 16 , wherein said polypeptide comprises an amino acid sequence that is at least 90% identical to the amino acid sequence of SEQ ID NO:2.

18. The method of claim 17 , wherein said polypeptide comprises an amino acid sequence that is at least 96% identical to the amino acid sequence of SEQ ID NO:2.

19. The method of claim 18 , wherein said polypeptide comprises an amino acid sequence that is at least 98% identical to the amino acid sequence of SEQ ID NO:2.

20. The method of claim 19 , wherein said microorganism is a bacterium of the species Corynebacterium glutamicum and, compared to said unmodified microorganism or starting strain, said modified microorganism comprises either:

a) an increased copy number of said polynucleotide; or

b) a stronger promoter controlling transcription of said polynucleotide.

Assignments (2)
CHANGE OF NAME Recorded Jan 26, 2020
From: EVONIK DEGUSSA GMBH
To: EVONIK OPERATIONS GMBH
Reel/Frame 051732/0931 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 27, 2012
From: WENDISCH, VOLKER F.; LINDNER, STEFFEN; BATHE, BRIGITTE; CLAES, WILFRIED
To: EVONIK DEGUSSA GMBH
Reel/Frame 027607/0337 →
Priority Claims (1)
DE 10 2009 030 342 · Jun 25, 2009 · national
Continuity (1)
Related Publication 20120164698A1 · Jun 28, 2012